Nview Health develops cloud-based behavioral health screening and monitoring solutions for healthcare professionals and research organizations. Led by CEO Jim Szyperski, its flagship offering is the M.I.N.I. (Mini International Neuropsychiatric Interview), a HIPAA-compliant, web-accessible tool usable on any web-enabled device including tablets and smartphones. The M.I.N.I. is a short, structured online interview that screens for more than 20 behavioral health disorders and can be administered in the office or at home. The tool has been used in research and clinical settings for more than 25 years, translated into 120 languages, deployed in over 100 countries, and referenced or validated in 10,000+ clinical trials. The M.I.N.I. has been accepted by the FDA and endorsed by the National Institutes of Health and the World Health Organization. Nview intends to use the $4.65M seed proceeds to bring vital behavioral health innovation to the broader medical community.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2019